Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 26, Issue 6, Pages 724-735
Publisher
SAGE Publications
Online
2021-10-10
DOI
10.1177/10742484211053109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
- (2019) Antonis A. Manolis et al. CURRENT HYPERTENSION REPORTS
- Prevention of Heart Failure in Hypertension—Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study
- (2019) Kyle Johnson et al. Journal of the American Heart Association
- RhoGTPase in Vascular Disease
- (2019) Derek Strassheim et al. Cells
- Effect of Early Normotension with Olmesartan on Rho-kinase Activity in Hypertensive Patients
- (2019) Claudio Cantin et al. Current Vascular Pharmacology
- Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
- (2019) Marc A Suchard et al. LANCET
- Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant HypertensionNovelty and Significance
- (2018) Eduardo M. Krieger et al. HYPERTENSION
- Hydrochlorothiazide and alternative diuretics versus renin–angiotensin system inhibitors for the regression of left ventricular hypertrophy
- (2018) George C. Roush et al. JOURNAL OF HYPERTENSION
- Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling
- (2018) Maria P. Ocaranza et al. CLINICAL SCIENCE
- Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure
- (2018) João Pedro Ferreira et al. HEART
- Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling
- (2018) Aurelie Nguyen Dinh Cat et al. Scientific Reports
- 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism
- (2018) Shinji Kishimoto et al. JOURNAL OF HYPERTENSION
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Jeffrey D Stanaway et al. LANCET
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Polarization microscopy as a tool for quantitative evaluation of collagen using picrosirius red in different stages of CKD in cats
- (2017) G. B. Morais et al. MICROSCOPY RESEARCH AND TECHNIQUE
- Global Disparities of Hypertension Prevalence and ControlClinical Perspective
- (2016) Katherine T. Mills et al. CIRCULATION
- Rho Kinases and Cardiac Remodeling
- (2016) Toru Shimizu et al. CIRCULATION JOURNAL
- RhoA/Rho-Kinase in the Cardiovascular System
- (2016) Hiroaki Shimokawa et al. CIRCULATION RESEARCH
- Simultaneous Rho kinase inhibition in circulating leukocytes and in cardiovascular tissue in rats with high angiotensin converting enzyme levels
- (2016) Camila Fierro et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients
- (2016) Riitta L. Antikainen et al. JOURNAL OF HYPERTENSION
- The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: Effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling
- (2015) Verdiana Ravarotto et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
- (2015) Bryan Williams et al. LANCET
- Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics
- (2014) Juan Tamargo et al. EXPERT OPINION ON PHARMACOTHERAPY
- The impact of high-normal blood pressure on left ventricular mechanics: a three-dimensional and speckle tracking echocardiography study
- (2014) Marijana Tadic et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Two- and Three-Dimensional Speckle Tracking Analysis of the Relation Between Myocardial Deformation and Functional Capacity in Patients With Systemic Hypertension
- (2013) Vera Celic et al. AMERICAN JOURNAL OF CARDIOLOGY
- Increased Rho-Kinase Activity in Hypertensive Patients With Left Ventricular Hypertrophy
- (2013) L. Gabrielli et al. AMERICAN JOURNAL OF HYPERTENSION
- Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment
- (2013) Peter M. Okin et al. BLOOD PRESSURE
- Chlorthalidone: Mechanisms of Action and Effect on Cardiovascular Events
- (2013) George C. Roush et al. CURRENT HYPERTENSION REPORTS
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans
- (2013) Caroline J. Smith et al. MICROVASCULAR RESEARCH
- Rho-Associated Kinase Activity, Endothelial Function, and Cardiovascular Risk Factors
- (2011) Junko Soga et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension
- (2011) N Fujimura et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension
- (2011) Yuichiro Yamada et al. HYPERTENSION RESEARCH
- Adding thiazide to a renin–angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension
- (2011) Hiroshi Ito et al. HYPERTENSION RESEARCH
- Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury
- (2011) H Tokuyama et al. INTERNATIONAL JOURNAL OF OBESITY
- Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1–9) axis in experimental hypertension
- (2011) María P Ocaranza et al. JOURNAL OF HYPERTENSION
- Risk Reduction After Regression of Echocardiographic Left Ventricular Hypertrophy in Hypertension: A Meta-Analysis
- (2010) S. D. Pierdomenico et al. AMERICAN JOURNAL OF HYPERTENSION
- Calcium channel blocker and Rho-associated kinase activity in patients with hypertension
- (2010) Takaki Hata et al. JOURNAL OF HYPERTENSION
- Regression of Left Ventricular Mass by Antihypertensive Treatment
- (2009) Robert H. Fagard et al. HYPERTENSION
- What Is Left Ventricular Hypertrophy and Is There a Reason to Regress Left Ventricular Hypertrophy?
- (2009) Matthew R. Weir et al. Journal of Clinical Hypertension
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More